Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial
出版年份 2013 全文链接
标题
Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 105, Issue 23, Pages 1789-1798
出版商
Oxford University Press (OUP)
发表日期
2013-11-15
DOI
10.1093/jnci/djt298
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
- (2017) Phillip G. Febbo et al. Journal of the National Comprehensive Cancer Network
- PTGS2 (Cyclooxygenase-2) Expression and Survival among Colorectal Cancer Patients: A Systematic Review
- (2013) A. T. Kunzmann et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Family History of Colorectal Cancer in BRAF p.V600E-Mutated Colorectal Cancer Cases
- (2013) D. D. Buchanan et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genomic Aberrations Occurring in Subsets of Serrated Colorectal Lesions but not Conventional Adenomas
- (2013) A. N. Burnett-Hartman et al. CANCER RESEARCH
- PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer
- (2013) F. L. Day et al. CLINICAL CANCER RESEARCH
- Coexistent mutations ofKRASandPIK3CAaffect the efficacy of NVP-BEZ235, a dual PI3K/MTOR inhibitor, in regulating the PI3K/MTOR pathway in colorectal cancer
- (2013) Areumnuri Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Descriptive profile of PIK3CA-mutated colorectal cancer in postmenopausal women
- (2013) Amanda I. Phipps et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
- (2013) Dora Colussi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
- (2013) Paul Lochhead et al. JNCI-Journal of the National Cancer Institute
- Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
- (2013) Christophe Rosty et al. MODERN PATHOLOGY
- Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations
- (2013) Chih-Chieh Chen et al. PLoS One
- PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
- (2013) Christophe Rosty et al. PLoS One
- Epigenetics and Colorectal Cancer Pathogenesis
- (2013) Kankana Bardhan et al. Cancers
- BRAF Mutation Status and Survival after Colorectal Cancer Diagnosis According to Patient and Tumor Characteristics
- (2012) A. I. Phipps et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers
- (2012) Y. Imamura et al. CLINICAL CANCER RESEARCH
- Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value
- (2012) P. G. Gavin et al. CLINICAL CANCER RESEARCH
- Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
- (2012) X. Liao et al. CLINICAL CANCER RESEARCH
- Common PIK3CA Mutants and a Novel 3' UTR Mutation Are Associated with Increased Sensitivity to Saracatinib
- (2012) J. J. Arcaroli et al. CLINICAL CANCER RESEARCH
- How many molecular subtypes? Implications of the unique tumor principle in personalized medicine
- (2012) Shuji Ogino et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Epigenetics of Colorectal Cancer
- (2012) Ajay Goel et al. GASTROENTEROLOGY
- Colorectal cancer: a tale of two sides or a continuum?: Figure 1
- (2012) Mai Yamauchi et al. GUT
- Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum
- (2012) Mai Yamauchi et al. GUT
- Identification of a Poor-PrognosisBRAF-Mutant–Like Population of Patients With Colon Cancer
- (2012) Vlad Popovici et al. JOURNAL OF CLINICAL ONCOLOGY
- Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair–Defective Colorectal Carcinomas
- (2012) William K. Funkhouser et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Dietary, lifestyle and clinicopathological factors associated with APC mutations and promoter methylation in colorectal cancers from the EPIC-Norfolk study
- (2012) Laura J Gay et al. JOURNAL OF PATHOLOGY
- Cancer classification using the Immunoscore: a worldwide task force
- (2012) Jérôme Galon et al. Journal of Translational Medicine
- Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X
- (2012) Chee-Seng Ku et al. MODERN PATHOLOGY
- Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer
- (2012) Alexandra Voutsina et al. MODERN PATHOLOGY
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms
- (2012) Whay Kuang Chia et al. Nature Reviews Clinical Oncology
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrative Cancer Epidemiology--The Next Generation
- (2012) M. R. Spitz et al. Cancer Discovery
- PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
- (2011) C. Mao et al. ANNALS OF ONCOLOGY
- Molecular alterations associated with liver metastases development in colorectal cancer patients
- (2011) S C Bruin et al. BRITISH JOURNAL OF CANCER
- Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
- (2011) S. Ogino et al. CLINICAL CANCER RESEARCH
- Oncogenic PIK3CA mutations in colorectal cancers and polyps
- (2011) Vicki L.J. Whitehall et al. INTERNATIONAL JOURNAL OF CANCER
- Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor
- (2011) Anna M Dahlin et al. MODERN PATHOLOGY
- Cancer immunology—analysis of host and tumor factors for personalized medicine
- (2011) Shuji Ogino et al. Nature Reviews Clinical Oncology
- Epigenetics and colorectal cancer
- (2011) Victoria Valinluck Lao et al. Nature Reviews Gastroenterology & Hepatology
- PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis
- (2011) Arantza Fariña Sarasqueta et al. CELLULAR ONCOLOGY
- Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment
- (2010) H. Dopeso et al. CLINICAL CANCER RESEARCH
- Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
- (2010) S. E. Baldus et al. CLINICAL CANCER RESEARCH
- Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab
- (2010) Jolien Tol et al. EUROPEAN JOURNAL OF CANCER
- Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
- (2010) S. Ogino et al. GUT
- Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review
- (2010) Katsuhiko Nosho et al. JOURNAL OF PATHOLOGY
- Lifestyle Factors and Microsatellite Instability in Colorectal Cancer: The Evolving Field of Molecular Pathological Epidemiology
- (2010) S. Ogino et al. JNCI-Journal of the National Cancer Institute
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Oncogenic mutations as predictive factors in colorectal cancer
- (2010) A Lièvre et al. ONCOGENE
- Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
- (2010) B Glimelius et al. PHARMACOGENOMICS JOURNAL
- Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
- (2009) J Souglakos et al. BRITISH JOURNAL OF CANCER
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
- (2009) A. Sartore-Bianchi et al. CANCER RESEARCH
- PIK3CA Mutations Are Not a Major Determinant of Resistance to the Epidermal Growth Factor Receptor Inhibitor Cetuximab in Metastatic Colorectal Cancer
- (2009) H. Prenen et al. CLINICAL CANCER RESEARCH
- PIK3CA Mutations Predict Local Recurrences in Rectal Cancer Patients
- (2009) Y. He et al. CLINICAL CANCER RESEARCH
- KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
- (2009) Monica M. Bertagnolli et al. JOURNAL OF CLINICAL ONCOLOGY
- PIK3CAMutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
- (2009) Shuji Ogino et al. JOURNAL OF CLINICAL ONCOLOGY
- CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
- (2008) S. Ogino et al. GUT
- Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
- (2008) Ludovic Barault et al. INTERNATIONAL JOURNAL OF CANCER
- Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population
- (2008) J Abubaker et al. ONCOGENE
- Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample
- (2008) Katsuhiko Nosho et al. PLoS One
- Helical domain and kinase domain mutations in p110 of phosphatidylinositol 3-kinase induce gain of function by different mechanisms
- (2008) L. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PIK3CAcancer mutations display gender and tissue specificity patterns
- (2007) Silvia Benvenuti et al. HUMAN MUTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation